These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9672232)
1. Cytokine profiles in HIV type 1 disease and protection. Shearer GM; Clerici M AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S149-52. PubMed ID: 9672232 [No Abstract] [Full Text] [Related]
2. Cytokines as adjuvants for improving anti-HIV responses. Morrow MP; Weiner DB AIDS; 2008 Jan; 22(3):333-8. PubMed ID: 18195559 [No Abstract] [Full Text] [Related]
3. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development. Heeney JL; Hahn BH AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855 [No Abstract] [Full Text] [Related]
4. Support for the RV144 HIV vaccine trial. Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455 [No Abstract] [Full Text] [Related]
5. Encouraging vaccine results from primate models of HIV type 1 infection. Schultz A AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S261-3. PubMed ID: 9814953 [TBL] [Abstract][Full Text] [Related]
6. Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576 [No Abstract] [Full Text] [Related]
11. Outwitting HIV: Minnesota researchers take on a clever virus. Bell H Minn Med; 2009 Oct; 92(10):22-6. PubMed ID: 19916268 [No Abstract] [Full Text] [Related]
12. Twenty years of HIV-1 research: what the future holds. Imami N; Gotch F Nat Immunol; 2003 Jun; 4(6):501. PubMed ID: 12774067 [No Abstract] [Full Text] [Related]
13. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword. Füst G Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613 [No Abstract] [Full Text] [Related]
14. HIV vaccine efficacy trials: towards the future of HIV prevention. Kim D; Elizaga M; Duerr A Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236 [TBL] [Abstract][Full Text] [Related]
15. Progress and obstacles in the development of an AIDS vaccine. Letvin NL Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514 [TBL] [Abstract][Full Text] [Related]
16. Development of prophylactic AIDS vaccines: the current state of affairs. Hanke T Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467 [TBL] [Abstract][Full Text] [Related]
17. Outstanding questions on HIV vaccine trial. Jefferys R; Harrington M Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456 [No Abstract] [Full Text] [Related]
18. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever? Egan MA Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741 [No Abstract] [Full Text] [Related]
19. A boost for the immune system. TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925 [TBL] [Abstract][Full Text] [Related]
20. Vaccine to prevent AIDS overstated. Lewis D Res Initiat Treat Action; 1999 Jan; 5(1):11-2. PubMed ID: 11366223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]